- Home
- GEN vs WST Comparison
GEN vs WST Comparison
Compare GEN & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEN
- WST
- Stock Information
- Founded
- GEN 1982
- WST 1923
- Country
- GEN United States
- WST United States
- Employees
- GEN N/A
- WST N/A
- Industry
- GEN Computer Software: Prepackaged Software
- WST Medical/Dental Instruments
- Sector
- GEN Technology
- WST Health Care
- Exchange
- GEN Nasdaq
- WST Nasdaq
- Market Cap
- GEN 18.6B
- WST 18.0B
- IPO Year
- GEN N/A
- WST N/A
- Fundamental
- Price
- GEN $27.35
- WST $279.76
- Analyst Decision
- GEN Buy
- WST Strong Buy
- Analyst Count
- GEN 7
- WST 8
- Target Price
- GEN $35.71
- WST $333.71
- AVG Volume (30 Days)
- GEN 3.1M
- WST 619.1K
- Earning Date
- GEN 11-06-2025
- WST 10-23-2025
- Dividend Yield
- GEN 1.84%
- WST 0.32%
- EPS Growth
- GEN 1.17
- WST N/A
- EPS
- GEN 0.96
- WST 6.68
- Revenue
- GEN $4,227,000,000.00
- WST $2,960,200,000.00
- Revenue This Year
- GEN $24.68
- WST $6.28
- Revenue Next Year
- GEN $5.06
- WST $6.11
- P/E Ratio
- GEN $28.34
- WST $41.80
- Revenue Growth
- GEN 10.60
- WST 2.90
- 52 Week Low
- GEN $22.74
- WST $187.43
- 52 Week High
- GEN $32.22
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- GEN 44.15
- WST 68.85
- Support Level
- GEN $26.32
- WST $260.12
- Resistance Level
- GEN $27.23
- WST $265.66
- Average True Range (ATR)
- GEN 0.51
- WST 5.66
- MACD
- GEN 0.04
- WST 0.63
- Stochastic Oscillator
- GEN 54.05
- WST 90.76
About GEN Gen Digital Inc.
Gen is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers. The firm's cyber safety offerings, via brands such as Norton, Avast, and LifeLock, have long maintained their positions as some of the most recognizable consumer-focused security and identity-protection products.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.